RDPAC药品推广行为准则 - IFPMA
RDPAC药品推广行为准则 - IFPMA
RDPAC药品推广行为准则 - IFPMA
- TAGS
- ifpma
- www.ifpma.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
研<br />
制<br />
开<br />
发<br />
制<br />
药<br />
企<br />
业<br />
协<br />
会<br />
知识与相应资格的雇员负责审批<br />
公司的药品推广材料,或是指定<br />
一名高级职员在具备足够资质的<br />
科研人员的指导下负责审批公司<br />
的药品推广材料。<br />
32<br />
第十二条 对准则的违反、投<br />
诉与准则的执行<br />
RDPAC鼓励会员公司就违反<br />
本准则的行为提出善意投诉。具体<br />
的投诉及对投诉的处理程序详见本<br />
准则附件二即《投诉及争议解决规<br />
程》。<br />
sufficient knowledge and appropriate<br />
qualifications should be responsible<br />
for approving all promotional communications.<br />
In the alternative, a senior<br />
company employee(s) could be made<br />
responsible provided that he or she<br />
receives scientific advice on such<br />
communications from adequately<br />
qualified scientific personnel.<br />
Article 12 Infringement, Complaints,<br />
and Enforcement<br />
Genuine complaints relating to infringements<br />
of the RDPAC Code are<br />
encouraged. Detailed procedures<br />
for complaints and the handling of<br />
complaints are set out in the RDPAC<br />
Complaint and Dispute Resolution<br />
Procedure (Appendix 2).
Change language